# Progress Note 01 — Initial plan

> **SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD**

- Patient: Thomas Jefferson (real historical name used in a fictional teaching record)
- Synthetic MRN: HR-EN005-SYN-TD
- Date: 1790-05-07
- Fictional facility: St. Posthumous Health Center
- Fictional author: Nathaniel Beaumont-Ruiz, MD
- Calendar frame: true historical dates (modern content is anachronistic)

> True-date frame: synthetic events are moved into the patient's historical lifetime. Codes, instruments, and treatments remain modern and are anachronistic.

## Subjective

The patient participates in this fictional visit for establishing primary care for recurrent disabling headaches, seven days into a bout: headache history and red-flag screen, a headache diary, disability and mood screening, acute treatment, avoiding medication overuse, and an old right wrist injury that slows his writing. **S**

## Objective

MIDAS 1, work days missed: 8 d; MIDAS 2, work days at half productivity or less: 14 d; MIDAS 3, household work days missed: 4 d; MIDAS 4, household days at half productivity or less: 6 d; MIDAS 5, family, social or leisure days missed: 7 d; PHQ-9: 6; GAD-7: 7; AUDIT-C: 3. All results are synthetic.

BP 126/80 mmHg; pulse 74 bpm; respirations 14/min; temperature 36.7 °C; oxygen saturation 98% on room air; weight 76 kg; BMI 21.3 kg/m². All vital signs are synthetic.

## Assessment

Active problems: Recurrent disabling headaches since early adulthood, in bouts lasting days to weeks, now in the seventh day of a bout; under evaluation, with a two-week headache diary and a headache medicine consultation; no red flags; Stiffness and weakness of the right wrist and hand after a dislocation that healed out of place in early middle age; writing is slow and painful after about an hour. Strengths and supports remain part of the care plan. **S**

## Medication changes

- Started: Naproxen 500 mg oral tablet, one tablet with food at the start of a headache, may repeat once after 12 hours; no more than two days a week **S**
- Started: Metoclopramide 10 mg oral tablet, one tablet with the naproxen when a headache brings nausea; no more than two days a week **S**

## Plan

- Diagnosis: a structured headache history, a red-flag screen (SNNOOP10) at every visit, a 14-day headache diary of attacks, features, triggers and medicine days, and ICHD-3 criteria; no neuroimaging for a stable long-standing pattern without red flags, with clear reasons that would change that. Guideline: Headache Classification Committee of the International Headache Society (IHS). The International Classification of Headache Disorders, 3rd edition (2018); The American Headache Society Consensus Statement: Update on integrating new migraine treatments into clinical practice (2021); Choosing wisely in headache medicine: the American Headache Society's list of five things physicians and patients should question (2013) **S**
- Neurology (headache medicine) consultation to confirm the diagnosis and advise on acute and preventive treatment. Guideline: The American Headache Society Consensus Statement: Update on integrating new migraine treatments into clinical practice (2021); Calcitonin gene-related peptide-targeting therapies are a first-line option for the prevention of migraine: An American Headache Society position statement update (2024) **S**
- Acute treatment at intake: naproxen early in an attack, with metoclopramide for nausea, no more than two days a week; stop the over-the-counter combination analgesic with caffeine; no opioids or butalbital. Guideline: The American Headache Society Position Statement On Integrating New Migraine Treatments Into Clinical Practice (2019); Pharmacologic Treatments of Acute Episodic Migraine Headache in Outpatient Settings: A Clinical Guideline From the American College of Physicians (2025); Choosing wisely in headache medicine: the American Headache Society's list of five things physicians and patients should question (2013) **S**
- Medication overuse headache prevention: acute-medicine days counted in the diary, with limits of fewer than 10 days a month for a triptan or combination analgesic and fewer than 15 for an NSAID; never caffeine pills or combination products. Guideline: Headache Classification Committee of the International Headache Society (IHS). The International Classification of Headache Disorders, 3rd edition (2018); The American Headache Society Consensus Statement: Update on integrating new migraine treatments into clinical practice (2021) **S**
- Lifestyle and triggers: a fixed wake and sleep time, regular meals on working days, a steady modest amount of caffeine, fluids, daily walks, and a stress plan for long working days with breaks from reading; relaxation training and biofeedback offered. Guideline: The American Headache Society Consensus Statement: Update on integrating new migraine treatments into clinical practice (2021) **S**
- Wrist and writing: an occupational therapy visit for hand function, a wrist splint for long writing sessions, dictation software, and a desk set up to spare the wrist and neck. Guideline: The American Headache Society Consensus Statement: Update on integrating new migraine treatments into clinical practice (2021) **S**
